NEW YORK (
CHANGE IN RATINGS
rated new Neutral at UBS. $44 price target. Margin compression and product changes cloud outlook.
First Majestic Silver
upgraded to hold at TheStreet Ratings.
upgraded to buy at TheStreet Ratings.
rated new Buy at UBS. $60 price target. Business mix shift will drive results and valuation improvement.
downgraded at Citigroup to Neutral from Buy, Citigroup said. $76 price target. Valuation call and lack of catalysts.
downgraded to sell at TheStreet Ratings.
BreitBurn Energy Partners
upgraded to buy at TheStreet Ratings.
downgraded at Jefferies to Hold from Buy, Jefferies said. $85 price target. Weakness outside the U.S.
downgraded at Jefferies to Hold from Buy, Jefferies said. $40 price target. Weakness outside the U.S.
downgraded at Stifel from Buy to Hold, Stifel Nicolaus said. Valuation call.
downgraded at JP Morgan to Underweight, JP Morgan said. Estimates also cut, given lower unit sales across the board.
downgraded at Argus from Buy to Hold, Argus said. Company is leveraged to a potential global slowdown.
upgraded at Credit Suisse from Neutral to Outperform, Credit Suisse said. $31 price target. Company is cutting costs and should post better volume growth.
rated new Buy at UBS. $43 price target. Attractive global growth opportunities through Alico.
upgraded at Compass Point from Neutral to Buy, Compass Point said. $30 price target. Entertainment sale should show the company's true earnings power.
downgraded at BMO from Outperform to Market Perform, BMO Capital said. Company is seeing lower market demand. $19 price target.
downgraded at Goldman from Neutral to Sell, Goldman Sachs said. Estimates also cut, given a weaker macro outlook. $9 price target.
downgraded at UBS to Neutral from Buy, UBS said. $13 price target. Downside risk limited, but few catalysts.
upgraded at Goldman from Neutral to Buy, Goldman Sachs said. Brand is rock solid. $70 price target.
downgraded at Wunderlich from Buy to Sell, Wunderlich said. $28 price target. Company seeing lower demand for the Model S vehicle.
upgraded at Drexel Hamilton from Hold to Buy, Drexel Hamilton said. $110 price target. Company is performing well, despite currency headwinds.
upgraded at Jefferies to Hold from Underperform, Jefferies said. $31 price target. FDA approval is a big win.
downgraded at Williams from Outperform to Perform, William Capital said. Valuation call, based on a $88 price target.
STOCK COMMENTS / EPS CHANGES
numbers raised at Jefferies. Shares of AMGN now seen reaching $88, Jefferies said. $88 price target. AMG-145 potential. Buy rating.
target raised at Oppenheimer to $46, Oppenheimer said. Take-out upside potential. Outperform rating.
numbers boosted at Credit Suisse. Shares of DTE now seen reaching $65, according to Credit Suisse. Estimates also upped, as the company is leveraged to the warmer weather. Outperform rating.
estimates, target lowered at Credit Suisse.EMC estimates were cut through 2013, Credit Suisse said. Company is being hurt by the soft macro environment. Outperform rating and new $30 price target.
estimates increased at Morgan Stanley through 2013, Morgan Stanley said. Company is seeing higher market activity and keeping a tight lid on costs. Equal-weight rating and $130 price target.
estimates reduced at BMO through 2013, BMO Capital said. Company reduced its guidance. Market Perform rating and $24 price target.
estimates lowered at UBS through 2013, UBS said. Slowing in Japan, China, Brazil, and Europe. Neutral rating and $77 price target.
Coca-Cola numbers reduced at Goldman. Shares of KO now seen reaching $81, according to Goldman Sachs. Estimates also cut, as the company is realizing lower margins. Buy rating.
estimates raised at UBS through 2014, UBS said. Slightly higher volumes, prices offset cost increases. Buy rating and $67 price target.
numbers raised at Credit Suisse. Shares of MTB now seen reaching $96, according to Credit Suisse. Estimates also increased, given higher loan growth. Neutral rating.
numbers cut at Morgan Stanley. Shares of WYNN now seen reaching $120, according to Morgan Stanley. Estimates also reduced, given decelerating growth. Equal-weight rating.
STRATEGY CALLS / MARKET CALLS
target lowered at Credit Suisse.SPX now seen reaching 1425, according to Credit Suisse. Expect lower earnings, especially out of Europe.
>To submit a news tip, email:
READERS ALSO LIKE:
and become a fan on
This article was written by a staff member of TheStreet.